Fat around the heart and risk of long-term diseases in Russia and Central Asia
Studies fat on the heart's surface and its links to chronic diseases.
Key facts
- Who runs it
- National Medical Research Center for Therapy and Preventive Medicine
- Where
- Moscow, RussiaSee the site
- Trial code
- Registry title
- Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 4 May 2026
- Expected to end
- Mar 2028
- Type of study
- Observational
- Record updated
- 22 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 50-70 years who are having a heart ultrasound (transthoracic echocardiography) in hospital or as outpatients. It studies fat on the surface of the heart.
- Age
- 50-70 years
- Sex
- All sexes can join.
Main reasons for not taking part
- Refusal to sign informed consent
- Cannot have a transthoracic echocardiography, or the images are of poor quality
- Severe psychiatric disorders
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients aged 50-70 years undergoing transthoracic echocardiography in inpatient or outpatient settings
- Ability and willingness to provide informed consent
Who cannot take part
- Severe psychiatric disorders
- Refusal to sign informed consent
- Inability to perform transthoracic echocardiography or poor image quality
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 70 years old?
Where in Russia
- National Medical Research Center for Therapy and Preventive MedicineMoscow, RussiaContact: Olga Dzhioeva, MD, Associate ProfessorTaking people
About the trial
What the trial wants to find out
Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function and contribute to structural and functional remodeling.
Read full original descriptionShow less
According to the literature, increased EFT thickness is associated with a wide range of NCDs, disease severity, and prognosis.
The aim of this study is to investigate the associations between EFT thickness and clinical and anamnestic parameters, as well as to evaluate the prognostic value of this parameter in patients aged 50-70 years from the Russian Federation, Kazakhstan, Uzbekistan, and Kyrgyzstan.
The group in the trial
- Observational cohort
Patients aged 50-70 years undergoing transthoracic echocardiography (TTE) in inpatient or outpatient
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Epicardial Fat Tissue Assessed by Echocardiography in Russian and Asian Populations: Association With Chronic Non-Communicable Diseases and Risk Factors
- Plain-language title
- Fat around the heart and risk of long-term diseases in Russia and Central AsiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07604610, who can take part
- Record updated
- 22 May 2026